Physical Rehabilitation Intervention With Protein Supplementation for People With Problematic Substance Use and Homelessness

NCT05700305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2023-05-12

No results posted yet for this study

Summary

Background: People who are homeless are more likely to experience poor mental health and addiction as well as suffering from non-communicable diseases. There is evidence of frailty and accelerated physical ageing among people experiencing homelessness. Appropriate physical rehabilitation and nutritional supplementation strategies can stabilize or reverse frailty and general physical decline, but it is not known how this type of intervention would work in practice in this population.

Aim: To evaluate the feasibility and preliminary efficacy of a physical rehabilitation drop in intervention with protein supplementation to target physical functioning and frailty in people with problematic substance use who are experiencing homelessness.

Methods: The intervention will consist of a 12-week low threshold physical rehabilitation program with protein supplementation. Participants will be service users of the Advance Ballyfermot Project, a day services center for people who are homeless and have active addiction issues. Primary outcomes will be feasibility including numbers recruited, retention of participants and number of repeat visits. Any adverse events will be recorded. Secondary outcomes will be strength and muscular mass, physical performance and lower extremity physical function, pain, frailty and nutritional status.

Conditions

Interventions

OTHER

12-week, low threshold physical rehabilitation intervention with protein supplementation

12 week, low threshold, rolling exercise intervention with protein supplementation

Sponsors & Collaborators

  • University of Dublin, Trinity College

    lead OTHER

Principal Investigators

  • Julie Broderick · University of Dublin, Trinity College

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-10
Primary Completion
2022-12-05
Completion
2023-03-10

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05700305 on ClinicalTrials.gov